Cognition and Cancer. Edited by Christina A. Meyers and James R. Perry
Herausgeber: Meyers, Christina A.; Perry, James R.
Cognition and Cancer. Edited by Christina A. Meyers and James R. Perry
Herausgeber: Meyers, Christina A.; Perry, James R.
- Broschiertes Buch
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
This book is essential reading for health care professionals involved in the clinical care of cancer patients with neurocognitive problems.
Andere Kunden interessierten sich auch für
- Catherine Rouby / Benoist Schaal / Danièle Dubois / Rémi Gervais / A. Holley (eds.)Olfaction, Taste, and Cognition185,99 €
- Sydney Blanshard FlowerThe Goat-gland Transplantation; As Originated and Successfully Performed by J. R. Brinkley, M. D., of Milford, Kansas, U. S. A., in Over 600 Operations Upon Men and Women18,99 €
- Neuroscience in the 21st Century415,99 €
- Harald SontheimerDiseases of the Nervous System175,99 €
- Paul PoirierTraité d'anatomie humaine. Publié sous la direction de P. Poirier et A. Charpy; Volume 550,99 €
- Th. RumpfArzt und R. V. O.109,95 €
- Semegnew Takele DessalegnUtilización del cinturón de seguridad entre los conductores de transporte público en A. A, Etiopía29,99 €
-
-
-
This book is essential reading for health care professionals involved in the clinical care of cancer patients with neurocognitive problems.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Produktdetails
- Produktdetails
- Verlag: Cambridge University Press
- Seitenzahl: 356
- Erscheinungstermin: 7. September 2012
- Englisch
- Abmessung: 246mm x 189mm x 19mm
- Gewicht: 689g
- ISBN-13: 9781107411814
- ISBN-10: 1107411815
- Artikelnr.: 37454259
- Herstellerkennzeichnung
- Libri GmbH
- Europaallee 1
- 36244 Bad Hersfeld
- gpsr@libri.de
- Verlag: Cambridge University Press
- Seitenzahl: 356
- Erscheinungstermin: 7. September 2012
- Englisch
- Abmessung: 246mm x 189mm x 19mm
- Gewicht: 689g
- ISBN-13: 9781107411814
- ISBN-10: 1107411815
- Artikelnr.: 37454259
- Herstellerkennzeichnung
- Libri GmbH
- Europaallee 1
- 36244 Bad Hersfeld
- gpsr@libri.de
Preface; List of contributors; Part I. Cognition and the Brain:
Measurement, Tools, and Interpretation: 1. Introduction Christina A. Meyers
and James R. Perry; 2. Clinical neuropsychology Jill B. Rich and Angela K.
Troyer; 3. Brain imaging investigation of chemotherapy-induced
neurocognitive changes Brenna C. McDonald, Andrew J. Saykin and Tim A.
Ahles; 4. Role of neuropsychological assessment in cancer patients Elana
Farace; 5. Neuropsychological assessment of adults with cancer Anne E.
Kayl, Robert Collins, and Jeffrey S. Wefel; 6. Neuropsychological
assessment of children with cancer Louise Penkman Fennell and Robert W.
Butler; Part II. Effects of Cancer and Cancer Treatment on Cognition: 7.
Biological bases of radiation injury to the brain Edward G. Shaw and Mike
E. Robbins; 8. Chemotherapy and biological response modifier-related
cognitive dysfunction Jeffrey S. Wefel, Robert Collins and Anne E. Kayl; 9.
Effect of hormones and hormonal treatment on cognition Christien Schilder,
Sanne Schagen and Frits van Dam; 10. Low grade gliomas Martin J. B.
Taphoorn and Charles G. Niel; 11. High grade gliomas Michael J. Glantz and
James R. Perry; 12. Brain metastases Deepak Khuntia, Beela S. Mathew,
Christina A. Meyers, Sterling Johnson and Minesh P. Mehta; 13. Primary
Central Nervous System lymphoma Denise D. Correa; 14. Childhood brain
tumors H. Stacy Nicholson, Louise Penkman Fennell and Robert W. Butler; 15.
Neurofibromatosis Bartlett D. Moore, III and John M. Slopis; 16.
Hematological malignancies Melissa Friedman and Mercedes Fernandez; 17.
Paraneoplastic disorders Edward Dropcho; 18. Symptomatic therapies and
supportive care issues Alan Valentine and Eduardo Bruera; 19. Animal models
and cancer related symptoms Adrian Dunn; Part III. Interventions and
Implications for Clinical Trials: 20. Behavioral strategies and
rehabilitation Dona E. C. Locke, Jane H. Cerhan and James F. Malec; 21.
Support services Bebe Guill and Renee H. Raynor; 22. Pharmacologic
interventions for the treatment of radiation-induced brain injury Edward G.
Shaw, Jerome Butler, L. Douglas Case, Ralph d'Agostino, Jr., John Gleason,
Jr., Edward Ip, Mike E. Robbins, Paul Saconn and Stephen R. Rapp; 23.
Neurocognitive testing in clinical trials Jennifer A. Smith and Jeffrey S.
Wefel.
Measurement, Tools, and Interpretation: 1. Introduction Christina A. Meyers
and James R. Perry; 2. Clinical neuropsychology Jill B. Rich and Angela K.
Troyer; 3. Brain imaging investigation of chemotherapy-induced
neurocognitive changes Brenna C. McDonald, Andrew J. Saykin and Tim A.
Ahles; 4. Role of neuropsychological assessment in cancer patients Elana
Farace; 5. Neuropsychological assessment of adults with cancer Anne E.
Kayl, Robert Collins, and Jeffrey S. Wefel; 6. Neuropsychological
assessment of children with cancer Louise Penkman Fennell and Robert W.
Butler; Part II. Effects of Cancer and Cancer Treatment on Cognition: 7.
Biological bases of radiation injury to the brain Edward G. Shaw and Mike
E. Robbins; 8. Chemotherapy and biological response modifier-related
cognitive dysfunction Jeffrey S. Wefel, Robert Collins and Anne E. Kayl; 9.
Effect of hormones and hormonal treatment on cognition Christien Schilder,
Sanne Schagen and Frits van Dam; 10. Low grade gliomas Martin J. B.
Taphoorn and Charles G. Niel; 11. High grade gliomas Michael J. Glantz and
James R. Perry; 12. Brain metastases Deepak Khuntia, Beela S. Mathew,
Christina A. Meyers, Sterling Johnson and Minesh P. Mehta; 13. Primary
Central Nervous System lymphoma Denise D. Correa; 14. Childhood brain
tumors H. Stacy Nicholson, Louise Penkman Fennell and Robert W. Butler; 15.
Neurofibromatosis Bartlett D. Moore, III and John M. Slopis; 16.
Hematological malignancies Melissa Friedman and Mercedes Fernandez; 17.
Paraneoplastic disorders Edward Dropcho; 18. Symptomatic therapies and
supportive care issues Alan Valentine and Eduardo Bruera; 19. Animal models
and cancer related symptoms Adrian Dunn; Part III. Interventions and
Implications for Clinical Trials: 20. Behavioral strategies and
rehabilitation Dona E. C. Locke, Jane H. Cerhan and James F. Malec; 21.
Support services Bebe Guill and Renee H. Raynor; 22. Pharmacologic
interventions for the treatment of radiation-induced brain injury Edward G.
Shaw, Jerome Butler, L. Douglas Case, Ralph d'Agostino, Jr., John Gleason,
Jr., Edward Ip, Mike E. Robbins, Paul Saconn and Stephen R. Rapp; 23.
Neurocognitive testing in clinical trials Jennifer A. Smith and Jeffrey S.
Wefel.
Preface; List of contributors; Part I. Cognition and the Brain:
Measurement, Tools, and Interpretation: 1. Introduction Christina A. Meyers
and James R. Perry; 2. Clinical neuropsychology Jill B. Rich and Angela K.
Troyer; 3. Brain imaging investigation of chemotherapy-induced
neurocognitive changes Brenna C. McDonald, Andrew J. Saykin and Tim A.
Ahles; 4. Role of neuropsychological assessment in cancer patients Elana
Farace; 5. Neuropsychological assessment of adults with cancer Anne E.
Kayl, Robert Collins, and Jeffrey S. Wefel; 6. Neuropsychological
assessment of children with cancer Louise Penkman Fennell and Robert W.
Butler; Part II. Effects of Cancer and Cancer Treatment on Cognition: 7.
Biological bases of radiation injury to the brain Edward G. Shaw and Mike
E. Robbins; 8. Chemotherapy and biological response modifier-related
cognitive dysfunction Jeffrey S. Wefel, Robert Collins and Anne E. Kayl; 9.
Effect of hormones and hormonal treatment on cognition Christien Schilder,
Sanne Schagen and Frits van Dam; 10. Low grade gliomas Martin J. B.
Taphoorn and Charles G. Niel; 11. High grade gliomas Michael J. Glantz and
James R. Perry; 12. Brain metastases Deepak Khuntia, Beela S. Mathew,
Christina A. Meyers, Sterling Johnson and Minesh P. Mehta; 13. Primary
Central Nervous System lymphoma Denise D. Correa; 14. Childhood brain
tumors H. Stacy Nicholson, Louise Penkman Fennell and Robert W. Butler; 15.
Neurofibromatosis Bartlett D. Moore, III and John M. Slopis; 16.
Hematological malignancies Melissa Friedman and Mercedes Fernandez; 17.
Paraneoplastic disorders Edward Dropcho; 18. Symptomatic therapies and
supportive care issues Alan Valentine and Eduardo Bruera; 19. Animal models
and cancer related symptoms Adrian Dunn; Part III. Interventions and
Implications for Clinical Trials: 20. Behavioral strategies and
rehabilitation Dona E. C. Locke, Jane H. Cerhan and James F. Malec; 21.
Support services Bebe Guill and Renee H. Raynor; 22. Pharmacologic
interventions for the treatment of radiation-induced brain injury Edward G.
Shaw, Jerome Butler, L. Douglas Case, Ralph d'Agostino, Jr., John Gleason,
Jr., Edward Ip, Mike E. Robbins, Paul Saconn and Stephen R. Rapp; 23.
Neurocognitive testing in clinical trials Jennifer A. Smith and Jeffrey S.
Wefel.
Measurement, Tools, and Interpretation: 1. Introduction Christina A. Meyers
and James R. Perry; 2. Clinical neuropsychology Jill B. Rich and Angela K.
Troyer; 3. Brain imaging investigation of chemotherapy-induced
neurocognitive changes Brenna C. McDonald, Andrew J. Saykin and Tim A.
Ahles; 4. Role of neuropsychological assessment in cancer patients Elana
Farace; 5. Neuropsychological assessment of adults with cancer Anne E.
Kayl, Robert Collins, and Jeffrey S. Wefel; 6. Neuropsychological
assessment of children with cancer Louise Penkman Fennell and Robert W.
Butler; Part II. Effects of Cancer and Cancer Treatment on Cognition: 7.
Biological bases of radiation injury to the brain Edward G. Shaw and Mike
E. Robbins; 8. Chemotherapy and biological response modifier-related
cognitive dysfunction Jeffrey S. Wefel, Robert Collins and Anne E. Kayl; 9.
Effect of hormones and hormonal treatment on cognition Christien Schilder,
Sanne Schagen and Frits van Dam; 10. Low grade gliomas Martin J. B.
Taphoorn and Charles G. Niel; 11. High grade gliomas Michael J. Glantz and
James R. Perry; 12. Brain metastases Deepak Khuntia, Beela S. Mathew,
Christina A. Meyers, Sterling Johnson and Minesh P. Mehta; 13. Primary
Central Nervous System lymphoma Denise D. Correa; 14. Childhood brain
tumors H. Stacy Nicholson, Louise Penkman Fennell and Robert W. Butler; 15.
Neurofibromatosis Bartlett D. Moore, III and John M. Slopis; 16.
Hematological malignancies Melissa Friedman and Mercedes Fernandez; 17.
Paraneoplastic disorders Edward Dropcho; 18. Symptomatic therapies and
supportive care issues Alan Valentine and Eduardo Bruera; 19. Animal models
and cancer related symptoms Adrian Dunn; Part III. Interventions and
Implications for Clinical Trials: 20. Behavioral strategies and
rehabilitation Dona E. C. Locke, Jane H. Cerhan and James F. Malec; 21.
Support services Bebe Guill and Renee H. Raynor; 22. Pharmacologic
interventions for the treatment of radiation-induced brain injury Edward G.
Shaw, Jerome Butler, L. Douglas Case, Ralph d'Agostino, Jr., John Gleason,
Jr., Edward Ip, Mike E. Robbins, Paul Saconn and Stephen R. Rapp; 23.
Neurocognitive testing in clinical trials Jennifer A. Smith and Jeffrey S.
Wefel.